Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 14Rectal Neoplasms 10Colonic Neoplasms 6Stomach Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 2Mesothelioma, Malignant 2Thrombocytopenia 1Squamous Cell Carcinoma of Head and Neck 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Liver, Cancer of, Primary Resectable 1Inoperable Esophageal Cancer Stage I-III 1Hepatocellular Carcinoma Resectable 1Hepatecellular Carcinoma 1Head and Neck Squamous Cell Cancer 1Fruquintinib 1Esophageal Squamous Cell Carcinoma 1Colorectal Cancer Metastatic 1Colon Cancer Liver Metastasis 1Carcinoma, Hepatocellular 1Advanced Metastatic Colorectal Cancer 1Advanced Gastric Cancer 1Advanced Colorectal Carcinoma 1Advanced Colorectal Cancer 1

Interventions

raltitrexed 1Irinotecan 1Cetuximab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Metastatic Colorectal Cancer × raltitrexed × Clear all
NCT05160896 2023-06-08

SALIRI Based Regimen as First-line Treatment for Advanced Metastatic Colorectal Cancer

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Unknown
90 enrolled
Gastrointestinal

Advanced Metastatic Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡